Gene Symbol | Gene ID | Gene Info |
---|---|---|
ID4
|
ENSG00000172201.6 | inhibitor of DNA binding 4, HLH protein |
TCF4
|
ENSG00000196628.9 | transcription factor 4 |
SNAI2
|
ENSG00000019549.4 | snail family transcriptional repressor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_19757618_19757769 | ID4 | 79924 | 0.100730 | -0.89 | 1.4e-03 | Click! |
chr6_19803783_19803934 | ID4 | 33759 | 0.195132 | -0.82 | 6.9e-03 | Click! |
chr6_19759286_19759437 | ID4 | 78256 | 0.103327 | -0.82 | 7.4e-03 | Click! |
chr6_19757317_19757468 | ID4 | 80225 | 0.100269 | -0.81 | 8.3e-03 | Click! |
chr6_19759574_19759725 | ID4 | 77968 | 0.103783 | -0.80 | 9.6e-03 | Click! |
chr8_49811749_49811900 | SNAI2 | 22164 | 0.274040 | -0.95 | 7.5e-05 | Click! |
chr8_49815894_49816045 | SNAI2 | 18019 | 0.286473 | -0.93 | 3.4e-04 | Click! |
chr8_49816752_49816903 | SNAI2 | 17161 | 0.288942 | -0.89 | 1.3e-03 | Click! |
chr8_49812416_49812567 | SNAI2 | 21497 | 0.276099 | -0.87 | 2.1e-03 | Click! |
chr8_49846554_49846705 | SNAI2 | 12330 | 0.300164 | -0.85 | 3.8e-03 | Click! |
chr18_53430605_53430756 | TCF4 | 98662 | 0.087228 | -0.95 | 1.1e-04 | Click! |
chr18_53457325_53457476 | TCF4 | 125382 | 0.060562 | -0.94 | 2.0e-04 | Click! |
chr18_52912778_52912929 | TCF4 | 30049 | 0.231082 | -0.93 | 2.2e-04 | Click! |
chr18_53400073_53400224 | TCF4 | 68130 | 0.139822 | -0.93 | 3.4e-04 | Click! |
chr18_53488838_53488989 | TCF4 | 156895 | 0.041632 | -0.92 | 3.7e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_133006516_133006696 | 8.25 |
MUC8 |
mucin 8 |
44120 |
0.14 |
chr9_134461722_134461957 | 6.10 |
RAPGEF1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
35386 |
0.14 |
chr12_65071338_65072263 | 5.77 |
AC025262.1 |
Mesenchymal stem cell protein DSC96; Uncharacterized protein |
18529 |
0.13 |
chr16_50308946_50309418 | 5.36 |
ADCY7 |
adenylate cyclase 7 |
1118 |
0.53 |
chr20_45027738_45027990 | 5.19 |
ELMO2 |
engulfment and cell motility 2 |
4743 |
0.24 |
chr19_7409723_7410061 | 5.09 |
CTB-133G6.1 |
|
3956 |
0.19 |
chr2_43360101_43360365 | 5.08 |
ENSG00000207087 |
. |
41601 |
0.18 |
chr3_43222761_43223220 | 5.00 |
ENSG00000222331 |
. |
29373 |
0.19 |
chr19_14550145_14550377 | 4.93 |
PKN1 |
protein kinase N1 |
811 |
0.48 |
chr15_89199975_89200176 | 4.84 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
17891 |
0.16 |
chr22_37631604_37631948 | 4.73 |
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
8512 |
0.14 |
chr21_36599978_36600337 | 4.68 |
RUNX1 |
runt-related transcription factor 1 |
178516 |
0.03 |
chr3_16355269_16355595 | 4.45 |
RP11-415F23.2 |
|
514 |
0.77 |
chr11_2320673_2321045 | 4.33 |
C11orf21 |
chromosome 11 open reading frame 21 |
2284 |
0.19 |
chr3_33089618_33090123 | 4.30 |
GLB1 |
galactosidase, beta 1 |
48414 |
0.11 |
chr11_1872642_1872992 | 4.24 |
LSP1 |
lymphocyte-specific protein 1 |
1383 |
0.25 |
chr9_134462401_134462737 | 4.10 |
RAPGEF1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
34656 |
0.14 |
chr21_45508804_45508955 | 4.05 |
PWP2 |
PWP2 periodic tryptophan protein homolog (yeast) |
18292 |
0.16 |
chr3_13055323_13055569 | 4.03 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
26910 |
0.23 |
chr17_56411933_56412610 | 3.93 |
ENSG00000264399 |
. |
1112 |
0.31 |
chr4_110568848_110569074 | 3.93 |
AC004067.5 |
|
44199 |
0.13 |
chr19_57182581_57182785 | 3.90 |
ZNF835 |
zinc finger protein 835 |
445 |
0.78 |
chr19_18809781_18809932 | 3.89 |
CRTC1 |
CREB regulated transcription coactivator 1 |
15368 |
0.14 |
chr16_68107852_68108775 | 3.87 |
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
10934 |
0.1 |
chr9_82498334_82498832 | 3.84 |
TLE4 |
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
176902 |
0.04 |
chr9_92141364_92141857 | 3.82 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
28565 |
0.19 |
chr2_65258478_65258686 | 3.80 |
AC007386.4 |
|
6049 |
0.18 |
chr10_130856557_130857124 | 3.79 |
MGMT |
O-6-methylguanine-DNA methyltransferase |
408608 |
0.01 |
chr7_50255789_50256070 | 3.79 |
AC020743.2 |
|
73510 |
0.1 |
chr2_99079929_99080200 | 3.76 |
INPP4A |
inositol polyphosphate-4-phosphatase, type I, 107kDa |
18651 |
0.22 |
chr16_75109617_75109896 | 3.75 |
ZNRF1 |
zinc and ring finger 1, E3 ubiquitin protein ligase |
28926 |
0.14 |
chr1_23853235_23853583 | 3.71 |
E2F2 |
E2F transcription factor 2 |
4303 |
0.21 |
chr16_68319405_68319752 | 3.71 |
ENSG00000252026 |
. |
1357 |
0.22 |
chr15_77293934_77294162 | 3.70 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
6133 |
0.21 |
chr6_131520209_131520483 | 3.70 |
AKAP7 |
A kinase (PRKA) anchor protein 7 |
785 |
0.78 |
chr1_226871894_226872507 | 3.69 |
ITPKB-IT1 |
ITPKB intronic transcript 1 (non-protein coding) |
9432 |
0.21 |
chr7_50251136_50251506 | 3.68 |
AC020743.2 |
|
68902 |
0.11 |
chr18_72075569_72075874 | 3.68 |
FAM69C |
family with sequence similarity 69, member C |
48782 |
0.14 |
chr2_128397341_128397685 | 3.67 |
LIMS2 |
LIM and senescent cell antigen-like domains 2 |
2193 |
0.23 |
chr9_7936150_7936848 | 3.66 |
TMEM261 |
transmembrane protein 261 |
136432 |
0.06 |
chr1_204255486_204255733 | 3.66 |
RP11-203F10.5 |
|
9476 |
0.2 |
chr1_11801284_11801657 | 3.64 |
AGTRAP |
angiotensin II receptor-associated protein |
5238 |
0.14 |
chr8_41999804_41999957 | 3.60 |
RP11-589C21.5 |
|
10401 |
0.17 |
chr21_32554369_32554681 | 3.59 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
51986 |
0.17 |
chr11_73687607_73687758 | 3.58 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
369 |
0.82 |
chr7_157419627_157419968 | 3.55 |
AC005481.5 |
Uncharacterized protein |
13082 |
0.23 |
chr19_47222188_47222384 | 3.53 |
PRKD2 |
protein kinase D2 |
1902 |
0.17 |
chr19_38908063_38908253 | 3.52 |
RASGRP4 |
RAS guanyl releasing protein 4 |
8644 |
0.09 |
chr17_74140903_74141711 | 3.52 |
RNF157-AS1 |
RNF157 antisense RNA 1 |
3710 |
0.14 |
chr11_67176002_67176390 | 3.51 |
TBC1D10C |
TBC1 domain family, member 10C |
4536 |
0.08 |
chr7_50251693_50252080 | 3.45 |
AC020743.2 |
|
69467 |
0.11 |
chr16_30198075_30198314 | 3.42 |
RP11-455F5.5 |
|
1916 |
0.14 |
chr1_60036490_60036813 | 3.41 |
FGGY |
FGGY carbohydrate kinase domain containing |
17061 |
0.29 |
chr10_7425063_7425214 | 3.40 |
SFMBT2 |
Scm-like with four mbt domains 2 |
25569 |
0.25 |
chr16_89827171_89827377 | 3.39 |
FANCA |
Fanconi anemia, complementation group A |
15804 |
0.12 |
chr17_8844881_8845564 | 3.39 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
23802 |
0.21 |
chr17_8856804_8857368 | 3.38 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
11938 |
0.24 |
chr17_66233684_66233962 | 3.37 |
AMZ2 |
archaelysin family metallopeptidase 2 |
9892 |
0.16 |
chr10_6134499_6134864 | 3.33 |
RBM17 |
RNA binding motif protein 17 |
3372 |
0.2 |
chr8_23078201_23078737 | 3.33 |
ENSG00000246582 |
. |
3515 |
0.14 |
chr2_106380554_106380705 | 3.31 |
NCK2 |
NCK adaptor protein 2 |
18441 |
0.27 |
chr5_148620356_148620568 | 3.31 |
ABLIM3 |
actin binding LIM protein family, member 3 |
2449 |
0.24 |
chr9_130541716_130542127 | 3.30 |
SH2D3C |
SH2 domain containing 3C |
901 |
0.36 |
chr15_78395791_78396151 | 3.29 |
SH2D7 |
SH2 domain containing 7 |
11044 |
0.13 |
chr19_30172057_30172430 | 3.29 |
PLEKHF1 |
pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
14462 |
0.21 |
chr19_16478953_16479699 | 3.29 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
6562 |
0.16 |
chr22_17584263_17584581 | 3.28 |
CECR6 |
cat eye syndrome chromosome region, candidate 6 |
17721 |
0.14 |
chr7_21469720_21469989 | 3.28 |
SP4 |
Sp4 transcription factor |
2193 |
0.3 |
chr8_1425105_1425428 | 3.27 |
DLGAP2 |
discs, large (Drosophila) homolog-associated protein 2 |
24266 |
0.27 |
chr11_67173408_67173659 | 3.27 |
TBC1D10C |
TBC1 domain family, member 10C |
1873 |
0.13 |
chr21_45509017_45509467 | 3.27 |
PWP2 |
PWP2 periodic tryptophan protein homolog (yeast) |
17929 |
0.16 |
chr3_107697956_107698544 | 3.24 |
CD47 |
CD47 molecule |
78958 |
0.11 |
chr7_8154178_8154625 | 3.24 |
AC006042.6 |
|
746 |
0.72 |
chr5_169785856_169786235 | 3.23 |
KCNIP1 |
Kv channel interacting protein 1 |
5554 |
0.21 |
chr6_159081449_159081842 | 3.22 |
SYTL3 |
synaptotagmin-like 3 |
706 |
0.68 |
chr9_95474571_95474832 | 3.22 |
IPPK |
inositol 1,3,4,5,6-pentakisphosphate 2-kinase |
42154 |
0.14 |
chr8_19414341_19414492 | 3.21 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
44960 |
0.2 |
chr2_103420061_103420470 | 3.21 |
TMEM182 |
transmembrane protein 182 |
41793 |
0.19 |
chr7_1781351_1781599 | 3.20 |
ELFN1 |
extracellular leucine-rich repeat and fibronectin type III domain containing 1 |
2758 |
0.28 |
chr10_73509908_73510091 | 3.20 |
C10orf54 |
chromosome 10 open reading frame 54 |
7388 |
0.2 |
chr2_233939760_233939982 | 3.19 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
14682 |
0.19 |
chr3_71924513_71924711 | 3.19 |
ENSG00000239250 |
. |
48284 |
0.16 |
chr15_77302641_77302975 | 3.19 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
5344 |
0.22 |
chr7_36817273_36817729 | 3.19 |
AOAH |
acyloxyacyl hydrolase (neutrophil) |
53347 |
0.14 |
chr17_76722732_76723209 | 3.17 |
CYTH1 |
cytohesin 1 |
1077 |
0.54 |
chr17_72739147_72739312 | 3.16 |
ENSG00000264624 |
. |
5523 |
0.1 |
chr21_47029758_47029909 | 3.15 |
PCBP3 |
poly(rC) binding protein 3 |
33775 |
0.18 |
chr14_55801558_55801974 | 3.14 |
RP11-665C16.5 |
|
4453 |
0.27 |
chr22_46635837_46636546 | 3.14 |
CDPF1 |
cysteine-rich, DPF motif domain containing 1 |
7991 |
0.15 |
chr1_226860558_226860816 | 3.12 |
ITPKB-IT1 |
ITPKB intronic transcript 1 (non-protein coding) |
2081 |
0.33 |
chr1_25886127_25886448 | 3.12 |
LDLRAP1 |
low density lipoprotein receptor adaptor protein 1 |
16216 |
0.19 |
chr14_105527534_105527887 | 3.12 |
GPR132 |
G protein-coupled receptor 132 |
3891 |
0.22 |
chr5_131336901_131337354 | 3.11 |
ACSL6 |
acyl-CoA synthetase long-chain family member 6 |
447 |
0.74 |
chr9_134139147_134139716 | 3.11 |
FAM78A |
family with sequence similarity 78, member A |
6449 |
0.18 |
chr1_7841463_7841653 | 3.10 |
PER3 |
period circadian clock 3 |
2822 |
0.2 |
chr14_90949773_90950033 | 3.10 |
RP11-471B22.2 |
|
78324 |
0.08 |
chr15_81594804_81595049 | 3.10 |
IL16 |
interleukin 16 |
3169 |
0.25 |
chr11_71165684_71166016 | 3.09 |
NADSYN1 |
NAD synthetase 1 |
1695 |
0.27 |
chr10_134871741_134871899 | 3.09 |
GPR123 |
G protein-coupled receptor 123 |
12613 |
0.2 |
chr4_2292182_2292444 | 3.09 |
ZFYVE28 |
zinc finger, FYVE domain containing 28 |
2871 |
0.18 |
chr10_7299238_7299582 | 3.07 |
SFMBT2 |
Scm-like with four mbt domains 2 |
151297 |
0.04 |
chr17_8844180_8844573 | 3.07 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
24648 |
0.2 |
chr2_240138107_240138258 | 3.07 |
HDAC4 |
histone deacetylase 4 |
25430 |
0.16 |
chr14_61918714_61918942 | 3.07 |
PRKCH |
protein kinase C, eta |
9552 |
0.25 |
chr7_151536517_151537055 | 3.04 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
24860 |
0.14 |
chr10_73511536_73512081 | 3.04 |
C10orf54 |
chromosome 10 open reading frame 54 |
5579 |
0.21 |
chr21_45616411_45616656 | 3.04 |
AP001057.1 |
|
4640 |
0.15 |
chr1_23852834_23853084 | 3.03 |
E2F2 |
E2F transcription factor 2 |
4753 |
0.2 |
chr7_50351161_50351383 | 3.02 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
2954 |
0.38 |
chr10_11254783_11255118 | 3.02 |
RP3-323N1.2 |
|
41611 |
0.16 |
chr14_99656353_99656504 | 3.02 |
AL162151.4 |
|
31675 |
0.2 |
chr10_73835799_73836159 | 3.01 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
12107 |
0.23 |
chr10_103594369_103594974 | 3.01 |
KCNIP2 |
Kv channel interacting protein 2 |
4476 |
0.17 |
chr16_70543044_70543249 | 3.01 |
COG4 |
component of oligomeric golgi complex 4 |
13957 |
0.11 |
chr4_184644425_184644694 | 2.98 |
ENSG00000251739 |
. |
17475 |
0.17 |
chr17_72457353_72457898 | 2.97 |
CD300A |
CD300a molecule |
4930 |
0.16 |
chr8_19372542_19372763 | 2.97 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
86724 |
0.1 |
chr6_137710963_137711301 | 2.96 |
OLIG3 |
oligodendrocyte transcription factor 3 |
104399 |
0.07 |
chr2_177858_178009 | 2.95 |
AC079779.7 |
|
19636 |
0.21 |
chr13_30946735_30946953 | 2.94 |
KATNAL1 |
katanin p60 subunit A-like 1 |
65223 |
0.12 |
chr15_78330921_78331370 | 2.94 |
ENSG00000221476 |
. |
272 |
0.88 |
chr17_8801323_8801785 | 2.94 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
13270 |
0.21 |
chr2_12271369_12271520 | 2.93 |
ENSG00000264089 |
. |
67812 |
0.13 |
chr8_27223358_27224128 | 2.93 |
PTK2B |
protein tyrosine kinase 2 beta |
14425 |
0.22 |
chr2_178065_178216 | 2.93 |
AC079779.7 |
|
19429 |
0.21 |
chr15_44960524_44961220 | 2.91 |
PATL2 |
protein associated with topoisomerase II homolog 2 (yeast) |
189 |
0.93 |
chr20_43276656_43276945 | 2.91 |
ADA |
adenosine deaminase |
3532 |
0.17 |
chr1_226085740_226085979 | 2.91 |
LEFTY1 |
left-right determination factor 1 |
9013 |
0.12 |
chr13_42943512_42943875 | 2.91 |
AKAP11 |
A kinase (PRKA) anchor protein 11 |
97404 |
0.08 |
chr14_104858355_104858716 | 2.90 |
ENSG00000222761 |
. |
8850 |
0.27 |
chr17_71588187_71588481 | 2.90 |
RP11-277J6.2 |
|
48831 |
0.13 |
chr20_50152923_50153423 | 2.89 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
6085 |
0.3 |
chr11_1873282_1874046 | 2.89 |
LSP1 |
lymphocyte-specific protein 1 |
536 |
0.61 |
chr14_91837015_91837436 | 2.89 |
ENSG00000265856 |
. |
37168 |
0.16 |
chr6_5833060_5833255 | 2.89 |
ENSG00000239472 |
. |
85920 |
0.1 |
chr13_30950302_30950776 | 2.88 |
KATNAL1 |
katanin p60 subunit A-like 1 |
68918 |
0.11 |
chr17_73121977_73122246 | 2.88 |
NT5C |
5', 3'-nucleotidase, cytosolic |
5242 |
0.09 |
chr9_131997515_131997814 | 2.88 |
ENSG00000220992 |
. |
4668 |
0.19 |
chr15_60855427_60855584 | 2.88 |
RORA |
RAR-related orphan receptor A |
29235 |
0.16 |
chr9_92137624_92138172 | 2.87 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
24853 |
0.2 |
chr11_2468048_2468289 | 2.87 |
KCNQ1 |
potassium voltage-gated channel, KQT-like subfamily, member 1 |
1947 |
0.26 |
chr13_24839780_24840285 | 2.87 |
SPATA13 |
spermatogenesis associated 13 |
4794 |
0.19 |
chr2_137139285_137139522 | 2.87 |
ENSG00000251976 |
. |
8499 |
0.31 |
chr14_106829445_106830187 | 2.87 |
IGHV4-34 |
immunoglobulin heavy variable 4-34 |
260 |
0.65 |
chr8_27235111_27235488 | 2.85 |
PTK2B |
protein tyrosine kinase 2 beta |
2869 |
0.31 |
chr1_227932356_227932702 | 2.84 |
SNAP47-AS1 |
SNAP47 antisense RNA 1 |
2363 |
0.24 |
chr14_91830283_91830819 | 2.82 |
ENSG00000265856 |
. |
30494 |
0.18 |
chr3_101503566_101503851 | 2.81 |
NXPE3 |
neurexophilin and PC-esterase domain family, member 3 |
536 |
0.76 |
chr3_71752260_71752853 | 2.81 |
EIF4E3 |
eukaryotic translation initiation factor 4E family member 3 |
21970 |
0.2 |
chr5_169725866_169726114 | 2.80 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
759 |
0.7 |
chr11_118097693_118098499 | 2.79 |
AMICA1 |
adhesion molecule, interacts with CXADR antigen 1 |
2287 |
0.23 |
chr16_1048534_1048745 | 2.79 |
SOX8 |
SRY (sex determining region Y)-box 8 |
16831 |
0.11 |
chr19_924018_924381 | 2.79 |
ARID3A |
AT rich interactive domain 3A (BRIGHT-like) |
1801 |
0.16 |
chr1_32314325_32314476 | 2.79 |
SPOCD1 |
SPOC domain containing 1 |
32748 |
0.13 |
chr12_4260916_4261263 | 2.79 |
CCND2 |
cyclin D2 |
121849 |
0.05 |
chr11_76397826_76398052 | 2.78 |
LRRC32 |
leucine rich repeat containing 32 |
16148 |
0.15 |
chr17_61662563_61662714 | 2.77 |
ENSG00000200560 |
. |
11932 |
0.13 |
chr19_35501572_35501736 | 2.77 |
GRAMD1A |
GRAM domain containing 1A |
10294 |
0.1 |
chr11_117821389_117821783 | 2.77 |
TMPRSS13 |
transmembrane protease, serine 13 |
21412 |
0.15 |
chr1_229335158_229335405 | 2.77 |
RP5-1061H20.5 |
|
28028 |
0.17 |
chr12_806266_806417 | 2.76 |
NINJ2 |
ninjurin 2 |
33396 |
0.14 |
chr9_132772376_132772571 | 2.76 |
FNBP1 |
formin binding protein 1 |
15327 |
0.2 |
chr9_95789474_95789633 | 2.76 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
12211 |
0.19 |
chr3_72457004_72457192 | 2.75 |
RYBP |
RING1 and YY1 binding protein |
38971 |
0.21 |
chr7_100846741_100846892 | 2.75 |
MOGAT3 |
monoacylglycerol O-acyltransferase 3 |
2514 |
0.14 |
chr7_50308759_50309184 | 2.75 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
35353 |
0.21 |
chr1_25359971_25360275 | 2.75 |
ENSG00000264371 |
. |
10129 |
0.23 |
chr19_7402225_7402456 | 2.75 |
CTB-133G6.1 |
|
11508 |
0.16 |
chr3_13452980_13453212 | 2.74 |
NUP210 |
nucleoporin 210kDa |
8713 |
0.25 |
chr19_11448818_11449159 | 2.72 |
RAB3D |
RAB3D, member RAS oncogene family |
1356 |
0.22 |
chr5_138851413_138851689 | 2.72 |
AC138517.1 |
Uncharacterized protein |
557 |
0.68 |
chr7_105313874_105314025 | 2.72 |
ATXN7L1 |
ataxin 7-like 1 |
5660 |
0.29 |
chr17_18943047_18943488 | 2.71 |
GRAP |
GRB2-related adaptor protein |
2531 |
0.17 |
chr3_183235187_183235622 | 2.71 |
KLHL6-AS1 |
KLHL6 antisense RNA 1 |
31119 |
0.12 |
chr1_26871950_26872101 | 2.71 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
318 |
0.85 |
chr22_30671598_30671900 | 2.71 |
OSM |
oncostatin M |
8920 |
0.1 |
chr12_123590684_123590835 | 2.70 |
PITPNM2 |
phosphatidylinositol transfer protein, membrane-associated 2 |
4216 |
0.22 |
chr1_198616246_198616560 | 2.70 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
8111 |
0.25 |
chr7_45016461_45016905 | 2.70 |
MYO1G |
myosin IG |
2014 |
0.23 |
chr16_84641040_84641383 | 2.70 |
COTL1 |
coactosin-like 1 (Dictyostelium) |
10454 |
0.17 |
chr16_84118584_84118936 | 2.70 |
MBTPS1 |
membrane-bound transcription factor peptidase, site 1 |
31640 |
0.1 |
chr12_112430741_112430919 | 2.70 |
TMEM116 |
transmembrane protein 116 |
12959 |
0.16 |
chr16_56261142_56261420 | 2.69 |
GNAO1 |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
990 |
0.54 |
chr2_231186113_231186438 | 2.69 |
SP140L |
SP140 nuclear body protein-like |
5624 |
0.26 |
chr3_47022127_47022407 | 2.68 |
NBEAL2 |
neurobeachin-like 2 |
1094 |
0.37 |
chr12_12635933_12636136 | 2.68 |
DUSP16 |
dual specificity phosphatase 16 |
38025 |
0.17 |
chr8_95954702_95954853 | 2.67 |
TP53INP1 |
tumor protein p53 inducible nuclear protein 1 |
1576 |
0.3 |
chr17_19037709_19038128 | 2.67 |
GRAPL |
GRB2-related adaptor protein-like |
1886 |
0.17 |
chr12_112431054_112431322 | 2.67 |
TMEM116 |
transmembrane protein 116 |
12601 |
0.16 |
chr1_226063156_226063499 | 2.66 |
TMEM63A |
transmembrane protein 63A |
2052 |
0.23 |
chr6_108103851_108104002 | 2.66 |
SCML4 |
sex comb on midleg-like 4 (Drosophila) |
10471 |
0.28 |
chr14_22969171_22969438 | 2.66 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
13133 |
0.1 |
chr10_11269625_11270026 | 2.66 |
RP3-323N1.2 |
|
56486 |
0.13 |
chr16_68307989_68308276 | 2.66 |
SLC7A6 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 |
1250 |
0.23 |
chr13_24827210_24827496 | 2.66 |
SPATA13-AS1 |
SPATA13 antisense RNA 1 |
1224 |
0.37 |
chr21_45566507_45566658 | 2.66 |
C21orf33 |
chromosome 21 open reading frame 33 |
10581 |
0.14 |
chr17_37250282_37250699 | 2.66 |
ENSG00000222494 |
. |
13172 |
0.14 |
chr8_29347582_29348013 | 2.66 |
RP4-676L2.1 |
|
137110 |
0.04 |
chr4_16125042_16125292 | 2.66 |
PROM1 |
prominin 1 |
39166 |
0.15 |
chr20_31123138_31123370 | 2.65 |
C20orf112 |
chromosome 20 open reading frame 112 |
946 |
0.55 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 15.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
3.6 | 28.8 | GO:0007172 | signal complex assembly(GO:0007172) |
3.4 | 10.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
3.3 | 13.1 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.8 | 8.5 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
2.7 | 8.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.7 | 13.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
2.6 | 7.9 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
2.4 | 14.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
2.2 | 6.6 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
2.2 | 6.5 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
2.2 | 2.2 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
2.1 | 2.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.0 | 10.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
2.0 | 4.0 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
2.0 | 5.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.9 | 9.7 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
1.9 | 1.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.9 | 1.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.8 | 5.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.7 | 5.1 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
1.7 | 6.8 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
1.7 | 5.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
1.7 | 1.7 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
1.7 | 3.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.6 | 18.9 | GO:0000303 | response to superoxide(GO:0000303) |
1.6 | 4.7 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
1.6 | 23.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.6 | 4.7 | GO:0006154 | adenosine catabolic process(GO:0006154) |
1.6 | 6.2 | GO:0000089 | mitotic metaphase(GO:0000089) |
1.5 | 4.6 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
1.5 | 4.5 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
1.5 | 4.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
1.5 | 7.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.5 | 7.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.4 | 5.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.4 | 11.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.4 | 1.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.4 | 1.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.4 | 6.8 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
1.3 | 8.1 | GO:0031060 | regulation of histone methylation(GO:0031060) |
1.3 | 12.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.3 | 6.6 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
1.3 | 4.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
1.3 | 4.0 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
1.3 | 4.0 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
1.3 | 2.6 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
1.3 | 6.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.3 | 3.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
1.3 | 1.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
1.3 | 13.0 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
1.3 | 5.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.2 | 3.7 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.2 | 96.7 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
1.2 | 2.4 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.2 | 3.6 | GO:1904035 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
1.2 | 3.6 | GO:0045056 | transcytosis(GO:0045056) |
1.2 | 1.2 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
1.2 | 3.5 | GO:0002507 | tolerance induction(GO:0002507) |
1.2 | 5.9 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
1.2 | 5.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.2 | 2.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.2 | 14.0 | GO:0031648 | protein destabilization(GO:0031648) |
1.2 | 4.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
1.2 | 11.5 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
1.2 | 1.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
1.1 | 1.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
1.1 | 2.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.1 | 4.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
1.1 | 5.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.1 | 4.5 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
1.1 | 3.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.1 | 3.3 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
1.1 | 1.1 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
1.1 | 4.4 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.1 | 6.6 | GO:0001782 | B cell homeostasis(GO:0001782) |
1.1 | 3.2 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
1.1 | 4.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.1 | 21.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
1.1 | 3.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
1.1 | 1.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.1 | 2.1 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
1.0 | 5.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.0 | 5.2 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
1.0 | 8.2 | GO:0006491 | N-glycan processing(GO:0006491) |
1.0 | 1.0 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
1.0 | 1.0 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
1.0 | 1.0 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
1.0 | 3.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
1.0 | 2.0 | GO:0033622 | integrin activation(GO:0033622) |
1.0 | 3.0 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
1.0 | 2.0 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
1.0 | 4.0 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
1.0 | 1.0 | GO:0048478 | replication fork protection(GO:0048478) |
1.0 | 4.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
1.0 | 4.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.0 | 2.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.0 | 4.9 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
1.0 | 3.0 | GO:0045759 | negative regulation of action potential(GO:0045759) |
1.0 | 8.8 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
1.0 | 6.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.0 | 2.9 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.9 | 4.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.9 | 3.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.9 | 4.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.9 | 18.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.9 | 1.9 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.9 | 2.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.9 | 0.9 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.9 | 0.9 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.9 | 2.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.9 | 12.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.9 | 3.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.9 | 1.8 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.9 | 6.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.9 | 0.9 | GO:0002925 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.9 | 4.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.9 | 0.9 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.9 | 0.9 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.9 | 3.6 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.9 | 2.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.9 | 0.9 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.9 | 2.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.9 | 6.2 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.9 | 0.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.9 | 3.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.9 | 2.6 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.9 | 4.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.9 | 3.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.9 | 2.6 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.9 | 3.4 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.9 | 0.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.9 | 0.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.8 | 26.9 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.8 | 3.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.8 | 2.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.8 | 2.5 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.8 | 3.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.8 | 16.6 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.8 | 2.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.8 | 8.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.8 | 1.6 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.8 | 5.7 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.8 | 1.6 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.8 | 2.5 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.8 | 0.8 | GO:0016556 | mRNA modification(GO:0016556) |
0.8 | 2.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.8 | 3.3 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.8 | 6.5 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.8 | 6.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.8 | 1.6 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.8 | 0.8 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.8 | 0.8 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.8 | 0.8 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.8 | 0.8 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) very-low-density lipoprotein particle clearance(GO:0034447) |
0.8 | 2.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.8 | 1.6 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.8 | 0.8 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.8 | 2.4 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.8 | 3.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.8 | 1.6 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.8 | 0.8 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.8 | 2.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.8 | 0.8 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.8 | 1.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.8 | 6.1 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.8 | 0.8 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.8 | 11.4 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.8 | 2.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.8 | 1.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.8 | 0.8 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.7 | 2.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.7 | 3.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.7 | 2.2 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.7 | 2.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.7 | 11.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.7 | 12.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.7 | 3.0 | GO:0072539 | T-helper cell lineage commitment(GO:0002295) alpha-beta T cell lineage commitment(GO:0002363) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) regulation of T-helper 17 cell lineage commitment(GO:2000328) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.7 | 1.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.7 | 0.7 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.7 | 2.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.7 | 3.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.7 | 2.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.7 | 0.7 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.7 | 2.2 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.7 | 3.6 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.7 | 2.1 | GO:0032328 | alanine transport(GO:0032328) |
0.7 | 1.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.7 | 1.4 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.7 | 1.4 | GO:0045006 | DNA deamination(GO:0045006) |
0.7 | 2.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.7 | 1.4 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.7 | 2.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.7 | 0.7 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
0.7 | 3.5 | GO:0030903 | notochord development(GO:0030903) |
0.7 | 8.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.7 | 1.4 | GO:0019042 | viral latency(GO:0019042) |
0.7 | 2.0 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.7 | 2.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.7 | 1.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.7 | 2.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.7 | 1.3 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.7 | 8.7 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.7 | 1.3 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.7 | 4.0 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.7 | 2.7 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.7 | 1.3 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.7 | 2.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.7 | 3.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.7 | 3.3 | GO:0032653 | regulation of interleukin-10 production(GO:0032653) |
0.7 | 10.6 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.7 | 3.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.7 | 3.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.7 | 2.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.7 | 3.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.7 | 1.3 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.7 | 8.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.7 | 4.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.7 | 0.7 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.7 | 24.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.7 | 3.9 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.6 | 1.9 | GO:0015669 | gas transport(GO:0015669) |
0.6 | 0.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.6 | 0.6 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.6 | 1.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 1.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 1.9 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.6 | 32.6 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.6 | 3.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.6 | 1.9 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.6 | 0.6 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.6 | 1.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.6 | 3.8 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.6 | 2.5 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.6 | 1.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.6 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.6 | 0.6 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.6 | 2.5 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.6 | 1.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 1.9 | GO:0032506 | cytokinetic process(GO:0032506) |
0.6 | 2.5 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.6 | 6.2 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.6 | 2.5 | GO:0001839 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.6 | 1.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 1.8 | GO:0003407 | neural retina development(GO:0003407) |
0.6 | 0.6 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.6 | 0.6 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.6 | 3.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.6 | 0.6 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
0.6 | 1.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 2.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.6 | 0.6 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.6 | 1.2 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.6 | 3.0 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.6 | 0.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.6 | 0.6 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.6 | 0.6 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.6 | 1.2 | GO:0048535 | lymph node development(GO:0048535) |
0.6 | 1.8 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.6 | 8.3 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.6 | 7.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.6 | 0.6 | GO:0060759 | regulation of response to cytokine stimulus(GO:0060759) |
0.6 | 1.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.6 | 0.6 | GO:0071503 | response to heparin(GO:0071503) |
0.6 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.6 | 2.9 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.6 | 2.9 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.6 | 4.1 | GO:0034311 | diol metabolic process(GO:0034311) |
0.6 | 0.6 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.6 | 1.2 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.6 | 1.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.6 | 2.9 | GO:0060023 | soft palate development(GO:0060023) |
0.6 | 0.6 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.6 | 1.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.6 | 0.6 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.6 | 6.9 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.6 | 5.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 2.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.6 | 9.7 | GO:0006903 | vesicle targeting(GO:0006903) |
0.6 | 1.7 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.6 | 0.6 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.6 | 0.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.6 | 15.9 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.6 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 1.1 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.6 | 1.1 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) endocardium formation(GO:0060214) |
0.6 | 4.5 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.6 | 1.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.6 | 1.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.6 | 2.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.6 | 3.9 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.6 | 1.7 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.6 | 2.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.6 | 1.7 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.6 | 0.6 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.6 | 0.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.6 | 1.7 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.5 | 0.5 | GO:0008228 | opsonization(GO:0008228) |
0.5 | 6.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.5 | 1.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.5 | 1.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.5 | 0.5 | GO:0014002 | astrocyte development(GO:0014002) |
0.5 | 1.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.5 | 1.6 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.5 | 1.1 | GO:0031033 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 4.3 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.5 | 2.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.5 | 2.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.5 | 4.3 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.5 | 2.1 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
0.5 | 1.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.5 | 1.6 | GO:0043276 | anoikis(GO:0043276) |
0.5 | 0.5 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.5 | 1.6 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.5 | 0.5 | GO:0042640 | anagen(GO:0042640) |
0.5 | 1.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.5 | 2.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.5 | 1.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.5 | 1.6 | GO:0070265 | necrotic cell death(GO:0070265) |
0.5 | 1.6 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.5 | 9.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.5 | 0.5 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.5 | 1.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 4.2 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.5 | 2.6 | GO:0009214 | cAMP catabolic process(GO:0006198) cyclic nucleotide catabolic process(GO:0009214) |
0.5 | 1.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.5 | 8.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.5 | 3.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 9.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.5 | 1.0 | GO:0014904 | myotube cell development(GO:0014904) |
0.5 | 5.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.5 | 1.0 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.5 | 0.5 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.5 | 7.6 | GO:0015893 | drug transport(GO:0015893) |
0.5 | 3.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.5 | 6.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.5 | 2.0 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.5 | 8.1 | GO:0006959 | humoral immune response(GO:0006959) |
0.5 | 0.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.5 | 1.5 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.5 | 3.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.5 | 6.0 | GO:0007032 | endosome organization(GO:0007032) |
0.5 | 2.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 1.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.5 | 2.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.5 | 2.5 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.5 | 0.5 | GO:0045058 | T cell selection(GO:0045058) |
0.5 | 1.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.5 | 1.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 1.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.5 | 0.5 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.5 | 1.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.5 | 1.0 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.5 | 0.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.5 | 2.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.5 | 0.5 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.5 | 2.9 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.5 | 0.5 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.5 | 3.9 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.5 | 1.9 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 1.9 | GO:0000154 | rRNA modification(GO:0000154) |
0.5 | 4.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.5 | 1.0 | GO:0015816 | glycine transport(GO:0015816) |
0.5 | 1.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.5 | 37.6 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.5 | 0.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.5 | 3.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.5 | 1.4 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.5 | 0.9 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.5 | 4.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) maintenance of protein localization in organelle(GO:0072595) |
0.5 | 1.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 0.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 1.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.5 | 0.9 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.5 | 0.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.5 | 0.9 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.5 | 0.9 | GO:0061054 | dermatome development(GO:0061054) |
0.5 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 1.4 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.5 | 2.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.5 | 0.5 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.5 | 1.8 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.5 | 3.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.5 | 1.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.5 | 1.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.5 | 1.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.5 | 0.9 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.5 | 1.8 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.5 | 7.7 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.5 | 0.9 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.5 | 0.5 | GO:0001967 | suckling behavior(GO:0001967) |
0.5 | 3.2 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 9.1 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.5 | 0.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.5 | 0.5 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.5 | 7.2 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.5 | 4.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.5 | 1.4 | GO:0017085 | response to insecticide(GO:0017085) |
0.5 | 0.9 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.4 | 8.1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.4 | 0.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.3 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 0.9 | GO:0072665 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.4 | 3.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.4 | 1.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 3.1 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.4 | 5.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.4 | 0.4 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.4 | 1.8 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.4 | 5.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.4 | 5.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.4 | 0.4 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.4 | 1.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.4 | 2.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.4 | 2.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.4 | 0.9 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.4 | 0.4 | GO:0042310 | vasoconstriction(GO:0042310) |
0.4 | 2.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.4 | 0.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 10.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.4 | 1.3 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.4 | 9.9 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.4 | 6.0 | GO:0050832 | defense response to fungus(GO:0050832) |
0.4 | 0.4 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.4 | 0.4 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.4 | 1.3 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 | 2.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.4 | 0.8 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.4 | 0.4 | GO:0051938 | L-glutamate import(GO:0051938) |
0.4 | 0.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.4 | 1.3 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.4 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 0.8 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.4 | 2.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.4 | 1.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.4 | 1.3 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.4 | 0.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 0.8 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.4 | 0.4 | GO:0043558 | regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
0.4 | 0.4 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.4 | 0.4 | GO:0001821 | histamine secretion(GO:0001821) |
0.4 | 0.8 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.4 | 1.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 0.4 | GO:0009069 | cysteine metabolic process(GO:0006534) serine family amino acid metabolic process(GO:0009069) |
0.4 | 0.4 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
0.4 | 0.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 0.8 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.4 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.4 | 1.6 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.4 | 1.6 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.4 | 0.4 | GO:0035411 | catenin import into nucleus(GO:0035411) regulation of catenin import into nucleus(GO:0035412) |
0.4 | 1.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.4 | 0.8 | GO:0060438 | trachea development(GO:0060438) |
0.4 | 0.8 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.4 | 2.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 0.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.4 | 6.7 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.4 | 2.0 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.4 | 0.4 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.4 | 1.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.4 | 1.6 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.4 | 1.6 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 3.1 | GO:0010001 | glial cell differentiation(GO:0010001) |
0.4 | 0.4 | GO:0046323 | glucose import(GO:0046323) |
0.4 | 0.4 | GO:0032418 | lysosome localization(GO:0032418) |
0.4 | 5.0 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.4 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 6.2 | GO:0035036 | cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.4 | 11.2 | GO:0046847 | filopodium assembly(GO:0046847) |
0.4 | 0.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.4 | 0.4 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.4 | 1.5 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 1.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.4 | 0.8 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.4 | 0.4 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.4 | 1.9 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.4 | 2.6 | GO:0030183 | B cell differentiation(GO:0030183) |
0.4 | 1.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.4 | 1.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 3.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 1.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 0.7 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.4 | 1.5 | GO:0019835 | cytolysis(GO:0019835) |
0.4 | 1.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.4 | 3.0 | GO:0007254 | JNK cascade(GO:0007254) |
0.4 | 8.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 0.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.4 | 15.8 | GO:0007498 | mesoderm development(GO:0007498) |
0.4 | 0.7 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.4 | 0.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.4 | 1.8 | GO:0001906 | cell killing(GO:0001906) |
0.4 | 1.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.4 | 0.4 | GO:0072676 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.4 | 1.5 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.4 | 4.7 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.4 | 1.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 1.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.4 | 0.7 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.4 | 2.9 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.4 | 1.8 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.4 | 1.8 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.4 | 1.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 0.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 0.7 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.4 | 0.4 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.4 | 1.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 3.5 | GO:0042098 | T cell proliferation(GO:0042098) |
0.4 | 1.4 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.4 | 1.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.4 | 0.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 0.4 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.3 | 1.7 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.3 | 0.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.3 | 1.7 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.3 | 1.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 1.7 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.3 | 1.4 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.3 | 1.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 1.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 0.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 3.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.3 | 0.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 1.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 1.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.3 | 0.3 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.3 | 0.7 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.3 | 5.1 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.3 | 2.7 | GO:0051322 | anaphase(GO:0051322) |
0.3 | 1.0 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 1.0 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 1.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 1.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 4.6 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.3 | 0.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.3 | 2.0 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 0.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 0.7 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.3 | 2.3 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.3 | 0.3 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.3 | 0.3 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.3 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 0.7 | GO:0043049 | otic placode formation(GO:0043049) |
0.3 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 3.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 0.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.3 | 0.3 | GO:0016045 | detection of bacterium(GO:0016045) |
0.3 | 0.3 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.3 | 14.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.3 | 0.3 | GO:0031427 | response to methotrexate(GO:0031427) |
0.3 | 1.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 0.6 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.3 | 0.9 | GO:0070295 | renal water absorption(GO:0070295) |
0.3 | 0.3 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) negative regulation of DNA biosynthetic process(GO:2000279) |
0.3 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 3.7 | GO:0051607 | defense response to virus(GO:0051607) |
0.3 | 11.5 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
0.3 | 0.6 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.3 | 3.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.3 | 1.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 0.3 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.3 | 6.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.3 | 0.9 | GO:0009301 | snRNA transcription(GO:0009301) |
0.3 | 0.6 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.3 | 0.6 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.3 | 2.8 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.3 | 0.9 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.3 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.3 | 0.3 | GO:0051197 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.3 | 1.5 | GO:0007632 | visual behavior(GO:0007632) |
0.3 | 0.3 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.3 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.3 | 4.0 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.3 | 0.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.3 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.3 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.3 | 0.3 | GO:0010819 | T cell chemotaxis(GO:0010818) regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) T cell migration(GO:0072678) regulation of lymphocyte chemotaxis(GO:1901623) regulation of lymphocyte migration(GO:2000401) positive regulation of lymphocyte migration(GO:2000403) regulation of T cell migration(GO:2000404) positive regulation of T cell migration(GO:2000406) |
0.3 | 0.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.3 | 0.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 0.3 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.3 | 1.2 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.3 | 0.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 0.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 1.5 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 2.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.3 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 1.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.3 | 1.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.3 | 0.9 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.3 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 0.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 0.6 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 3.8 | GO:0071616 | fatty-acyl-CoA metabolic process(GO:0035337) thioester biosynthetic process(GO:0035384) fatty-acyl-CoA biosynthetic process(GO:0046949) acyl-CoA biosynthetic process(GO:0071616) |
0.3 | 2.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.3 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) negative regulation of DNA recombination(GO:0045910) |
0.3 | 0.3 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.3 | 0.3 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.3 | 1.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.3 | 0.6 | GO:0001510 | RNA methylation(GO:0001510) |
0.3 | 0.3 | GO:0051608 | histamine transport(GO:0051608) |
0.3 | 1.4 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.3 | 0.9 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 2.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 1.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 0.9 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 0.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.3 | GO:0021779 | oligodendrocyte cell fate commitment(GO:0021779) |
0.3 | 0.6 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.3 | 0.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.3 | 7.9 | GO:0042384 | cilium assembly(GO:0042384) |
0.3 | 1.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 0.8 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.3 | 0.6 | GO:0003416 | endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
0.3 | 1.9 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.3 | 0.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.3 | 1.9 | GO:0045851 | pH reduction(GO:0045851) |
0.3 | 20.5 | GO:0050776 | regulation of immune response(GO:0050776) |
0.3 | 1.1 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.3 | 1.7 | GO:0045010 | actin nucleation(GO:0045010) |
0.3 | 2.5 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.3 | 0.5 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.3 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 9.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.3 | 0.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 2.7 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.3 | 1.4 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.3 | 0.3 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.3 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 0.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 2.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 0.5 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 0.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 1.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 0.8 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.3 | 2.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.3 | 0.3 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.3 | 1.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.3 | 9.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 1.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.3 | 2.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 0.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 1.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 1.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.3 | 0.5 | GO:0006304 | DNA modification(GO:0006304) |
0.3 | 0.3 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.3 | 0.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.3 | 6.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 2.3 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.3 | 11.2 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.3 | 26.2 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.3 | 0.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.3 | 4.1 | GO:0043487 | regulation of RNA stability(GO:0043487) regulation of mRNA stability(GO:0043488) |
0.3 | 1.5 | GO:0000084 | mitotic S phase(GO:0000084) |
0.3 | 0.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.3 | 0.5 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.3 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 2.0 | GO:0006862 | nucleotide transport(GO:0006862) |
0.3 | 2.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.3 | 8.8 | GO:0007051 | spindle organization(GO:0007051) |
0.3 | 2.8 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.3 | 1.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.3 | 1.8 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.3 | 0.8 | GO:0015695 | organic cation transport(GO:0015695) |
0.2 | 0.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 0.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 2.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 1.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 4.4 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.2 | 1.7 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.2 | 0.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 4.2 | GO:0017148 | negative regulation of translation(GO:0017148) negative regulation of cellular amide metabolic process(GO:0034249) |
0.2 | 0.5 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.2 | 6.3 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.2 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 1.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 1.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.2 | 2.4 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.2 | 1.4 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 0.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.2 | 2.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.9 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.2 | 2.4 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.2 | 0.5 | GO:0001832 | blastocyst growth(GO:0001832) |
0.2 | 3.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 1.4 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 3.5 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.2 | 1.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 1.9 | GO:0090501 | mRNA cleavage(GO:0006379) RNA phosphodiester bond hydrolysis(GO:0090501) |
0.2 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 48.3 | GO:0006397 | mRNA processing(GO:0006397) |
0.2 | 0.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 0.5 | GO:0044819 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
0.2 | 47.8 | GO:0006955 | immune response(GO:0006955) |
0.2 | 0.2 | GO:1902583 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.2 | 3.0 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.2 | 5.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 0.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.2 | 1.9 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.2 | 1.6 | GO:0006241 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.2 | 0.5 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.2 | 0.2 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.2 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.2 | 9.3 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
0.2 | 0.2 | GO:0031623 | receptor internalization(GO:0031623) |
0.2 | 1.8 | GO:0042044 | fluid transport(GO:0042044) |
0.2 | 0.7 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 0.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 0.7 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.4 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.2 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 0.4 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.2 | 2.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 3.3 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.2 | 0.7 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 0.2 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.2 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.4 | GO:0045321 | leukocyte activation(GO:0045321) |
0.2 | 0.4 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.2 | 1.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 0.2 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.2 | 0.2 | GO:1903523 | negative regulation of blood circulation(GO:1903523) |
0.2 | 0.4 | GO:0044241 | lipid digestion(GO:0044241) |
0.2 | 2.0 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.2 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.5 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.2 | 0.9 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
0.2 | 1.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.2 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.2 | 1.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.2 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.2 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 2.3 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) cellular response to topologically incorrect protein(GO:0035967) |
0.2 | 0.2 | GO:0006325 | chromatin organization(GO:0006325) |
0.2 | 0.2 | GO:0051329 | mitotic interphase(GO:0051329) |
0.2 | 1.7 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.2 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 1.7 | GO:0046649 | lymphocyte activation(GO:0046649) |
0.2 | 0.4 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 2.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.4 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.2 | 0.8 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.2 | 0.8 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 5.9 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.2 | 0.6 | GO:0061647 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.2 | 0.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.2 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.4 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 3.7 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.2 | 0.4 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 0.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.2 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.2 | 1.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.4 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.2 | 2.4 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.2 | 0.8 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.4 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.2 | 1.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 1.4 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 0.4 | GO:0051917 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.2 | 2.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.6 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.2 | 0.6 | GO:0016447 | somatic recombination of immunoglobulin gene segments(GO:0016447) |
0.2 | 0.6 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.2 | 0.6 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.2 | 0.2 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.2 | 0.8 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.2 | 0.4 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.2 | 0.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.2 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.2 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.2 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 7.4 | GO:0006413 | translational initiation(GO:0006413) |
0.2 | 1.7 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 0.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 3.9 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.2 | 0.8 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.2 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.5 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.2 | 6.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 2.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 29.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.2 | 0.6 | GO:0006323 | DNA packaging(GO:0006323) |
0.2 | 0.6 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.2 | 0.9 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 0.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 0.6 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.2 | 0.9 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.2 | 1.3 | GO:0001662 | behavioral fear response(GO:0001662) |
0.2 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 1.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 2.8 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.2 | 0.7 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 0.5 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
0.2 | 4.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 0.4 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.2 | 2.4 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) negative regulation of cellular protein catabolic process(GO:1903363) |
0.2 | 12.4 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.2 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.4 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.2 | 0.2 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.2 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.9 | GO:0061371 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.2 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.2 | 0.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.3 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 0.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 1.4 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 2.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 1.4 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.2 | 0.5 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.2 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 1.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.7 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.7 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.2 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.3 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.2 | 0.2 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.2 | 0.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 10.9 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.2 | 1.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.2 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.2 | 0.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 1.1 | GO:0051899 | membrane depolarization(GO:0051899) |
0.2 | 1.9 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 2.3 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.2 | 0.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 5.1 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.2 | 1.9 | GO:0022406 | membrane docking(GO:0022406) |
0.2 | 0.3 | GO:0021940 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) regulation of cerebellar granule cell precursor proliferation(GO:0021936) cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.2 | 0.5 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.2 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.8 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.2 | 0.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.2 | GO:0044254 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.2 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 1.1 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.2 | 7.5 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.1 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 14.0 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.4 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.1 | 9.6 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.1 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.1 | 0.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.8 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.4 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.6 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) |
0.1 | 1.7 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 8.9 | GO:0001775 | cell activation(GO:0001775) |
0.1 | 0.8 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.1 | 2.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.1 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 2.4 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 18.2 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 1.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 2.8 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.9 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 2.0 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 6.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 17.3 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 1.0 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 0.5 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.9 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) deoxyribose phosphate catabolic process(GO:0046386) |
0.1 | 0.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 0.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.1 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.1 | 2.4 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.3 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 2.5 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.5 | GO:0009416 | response to light stimulus(GO:0009416) |
0.1 | 0.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.9 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 1.1 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.1 | 0.5 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 2.9 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.2 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.1 | 0.6 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.1 | 0.1 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 1.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.7 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.1 | GO:0034445 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.4 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.1 | 0.1 | GO:0030432 | peristalsis(GO:0030432) positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.9 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.2 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle organ development(GO:0048635) negative regulation of muscle tissue development(GO:1901862) |
0.1 | 0.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.7 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.1 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 10.5 | GO:0006869 | lipid transport(GO:0006869) |
0.1 | 0.2 | GO:0060021 | palate development(GO:0060021) |
0.1 | 0.3 | GO:0065002 | intracellular protein transmembrane import(GO:0044743) intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 12.0 | GO:0034220 | ion transmembrane transport(GO:0034220) |
0.1 | 0.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.9 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 1.0 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.3 | GO:0001704 | formation of primary germ layer(GO:0001704) |
0.1 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.1 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 0.1 | GO:0009415 | response to water(GO:0009415) |
0.1 | 0.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.2 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.1 | 3.4 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.1 | 1.0 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.1 | 0.2 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.1 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.3 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 0.3 | GO:0046849 | bone remodeling(GO:0046849) |
0.1 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 1.4 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.6 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 1.6 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.4 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.1 | 2.6 | GO:0006887 | exocytosis(GO:0006887) |
0.1 | 0.7 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.1 | 2.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.2 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.1 | 0.3 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.1 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 9.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.4 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.8 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.1 | GO:0072243 | metanephric collecting duct development(GO:0072205) metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:0072109 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) glomerulus vasculature development(GO:0072012) glomerular mesangium development(GO:0072109) |
0.1 | 1.0 | GO:0007338 | single fertilization(GO:0007338) |
0.1 | 0.2 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.1 | 0.3 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.1 | 0.2 | GO:0018065 | protein lipoylation(GO:0009249) protein-cofactor linkage(GO:0018065) |
0.1 | 7.3 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 1.5 | GO:0061025 | membrane fusion(GO:0061025) |
0.1 | 0.9 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 0.2 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 1.1 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 1.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.1 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.1 | 0.6 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.1 | 4.2 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.1 | 0.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.1 | 0.9 | GO:0070997 | neuron death(GO:0070997) |
0.1 | 1.8 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.9 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.2 | GO:0042461 | photoreceptor cell development(GO:0042461) eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.5 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.1 | 0.1 | GO:0002831 | regulation of response to biotic stimulus(GO:0002831) |
0.1 | 0.1 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.1 | GO:0042312 | regulation of vasodilation(GO:0042312) |
0.1 | 0.1 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.1 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 23.0 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 3.6 | GO:0044403 | symbiosis, encompassing mutualism through parasitism(GO:0044403) |
0.1 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.4 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.8 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.1 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.1 | 5.5 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.1 | 6.5 | GO:0006952 | defense response(GO:0006952) |
0.1 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 4.3 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.1 | 0.4 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 0.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.6 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.0 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.0 | 0.2 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.2 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.5 | GO:0043254 | regulation of protein complex assembly(GO:0043254) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0045768 | obsolete positive regulation of anti-apoptosis(GO:0045768) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0098727 | maintenance of cell number(GO:0098727) |
0.0 | 1.4 | GO:0007034 | vacuolar transport(GO:0007034) |
0.0 | 1.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.0 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.0 | 0.0 | GO:0072044 | collecting duct development(GO:0072044) |
0.0 | 9.5 | GO:0012501 | programmed cell death(GO:0012501) |
0.0 | 0.1 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
0.0 | 35.3 | GO:0051252 | regulation of RNA metabolic process(GO:0051252) |
0.0 | 1.2 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.0 | 0.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 0.0 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 1.8 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.2 | GO:0031279 | regulation of cyclase activity(GO:0031279) |
0.0 | 0.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.1 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.2 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.0 | 0.1 | GO:0009451 | RNA modification(GO:0009451) |
0.0 | 0.4 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.0 | 0.0 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.1 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.6 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.0 | 5.9 | GO:0015031 | protein transport(GO:0015031) |
0.0 | 0.0 | GO:0071695 | anatomical structure maturation(GO:0071695) |
0.0 | 0.0 | GO:0030004 | cellular monovalent inorganic cation homeostasis(GO:0030004) |
0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0007369 | gastrulation(GO:0007369) |
0.0 | 0.1 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 2.7 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.0 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.0 | GO:0010043 | response to zinc ion(GO:0010043) |
0.0 | 0.0 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.1 | 8.4 | GO:0043218 | compact myelin(GO:0043218) |
2.0 | 8.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.9 | 15.5 | GO:0001891 | phagocytic cup(GO:0001891) |
1.9 | 5.6 | GO:0032009 | early phagosome(GO:0032009) |
1.7 | 10.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.5 | 4.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.5 | 4.6 | GO:0072487 | MSL complex(GO:0072487) |
1.5 | 13.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.5 | 4.5 | GO:0044462 | external encapsulating structure part(GO:0044462) |
1.5 | 4.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.5 | 15.0 | GO:0001772 | immunological synapse(GO:0001772) |
1.5 | 4.4 | GO:0005884 | actin filament(GO:0005884) |
1.4 | 19.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.3 | 3.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.3 | 5.2 | GO:0005667 | transcription factor complex(GO:0005667) |
1.2 | 1.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.2 | 2.4 | GO:0012505 | endomembrane system(GO:0012505) |
1.2 | 3.6 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
1.2 | 5.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.2 | 2.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.2 | 2.4 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
1.1 | 7.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.1 | 5.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.1 | 5.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.1 | 8.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
1.0 | 7.3 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
1.0 | 2.1 | GO:0031932 | TORC2 complex(GO:0031932) |
1.0 | 4.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.0 | 1.0 | GO:0001740 | sex chromosome(GO:0000803) X chromosome(GO:0000805) Barr body(GO:0001740) |
1.0 | 3.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.9 | 2.8 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.9 | 0.9 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.9 | 5.5 | GO:0000791 | euchromatin(GO:0000791) |
0.9 | 5.5 | GO:0005883 | neurofilament(GO:0005883) |
0.9 | 2.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.9 | 3.6 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.9 | 2.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.8 | 4.2 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.8 | 5.0 | GO:0045179 | apical cortex(GO:0045179) |
0.8 | 1.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.8 | 6.6 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.8 | 9.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.8 | 2.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.8 | 2.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.8 | 0.8 | GO:0030684 | preribosome(GO:0030684) |
0.8 | 2.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.8 | 1.6 | GO:0031904 | endosome lumen(GO:0031904) |
0.8 | 2.3 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.8 | 4.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 3.8 | GO:0070695 | FHF complex(GO:0070695) |
0.8 | 2.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.8 | 3.8 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.7 | 0.7 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.7 | 7.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 10.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.7 | 2.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.7 | 0.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 4.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.7 | 6.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.7 | 2.7 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.7 | 6.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.7 | 1.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 3.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.6 | 0.6 | GO:0042827 | platelet dense granule(GO:0042827) |
0.6 | 0.6 | GO:0031090 | organelle membrane(GO:0031090) |
0.6 | 5.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.6 | 1.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.6 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 21.4 | GO:0030175 | filopodium(GO:0030175) |
0.6 | 6.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.6 | 5.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 27.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.6 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.6 | 6.5 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.6 | 2.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 0.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.6 | 6.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.6 | 9.6 | GO:0005844 | polysome(GO:0005844) |
0.6 | 7.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.6 | 16.3 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.6 | 2.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.6 | 1.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.6 | 6.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.5 | 5.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 2.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 2.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 0.5 | GO:0000800 | lateral element(GO:0000800) |
0.5 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 2.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.5 | 1.0 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.5 | 27.8 | GO:0016605 | PML body(GO:0016605) |
0.5 | 1.5 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.5 | 3.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 1.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 3.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.5 | 1.0 | GO:0043235 | receptor complex(GO:0043235) |
0.5 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 1.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.5 | 1.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.5 | 8.1 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.5 | 5.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.5 | 3.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.5 | 1.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 1.4 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.5 | 2.8 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.5 | 16.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.5 | 2.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 0.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.5 | 1.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.5 | 4.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 1.4 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.5 | 0.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.5 | 4.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 1.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 21.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.4 | 5.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.4 | 2.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 9.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 1.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 7.0 | GO:0032420 | stereocilium(GO:0032420) |
0.4 | 9.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 0.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.4 | 0.9 | GO:0030904 | retromer complex(GO:0030904) |
0.4 | 0.8 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.4 | 4.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.4 | 23.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 2.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 1.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 7.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 1.2 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 7.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.4 | 4.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 1.6 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.4 | 3.6 | GO:1904949 | cation-transporting ATPase complex(GO:0090533) ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.4 | 0.4 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.4 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 4.3 | GO:0090568 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.4 | 29.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.4 | 5.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 2.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 0.8 | GO:0016235 | aggresome(GO:0016235) |
0.4 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 1.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 44.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 3.0 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 1.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 2.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.4 | 1.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.4 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 1.4 | GO:0033011 | perinuclear theca(GO:0033011) |
0.4 | 2.1 | GO:0000792 | heterochromatin(GO:0000792) |
0.4 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 1.4 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 0.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 2.7 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.3 | 2.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 2.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 6.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 2.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 10.4 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 4.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 4.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 3.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 1.7 | GO:0001741 | XY body(GO:0001741) |
0.3 | 9.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 1.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 7.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 1.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 11.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 29.4 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.3 | 2.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 1.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.3 | 28.3 | GO:0005938 | cell cortex(GO:0005938) |
0.3 | 1.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 5.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 2.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 0.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 2.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.3 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 3.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 0.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 1.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 2.5 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.3 | 1.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.3 | 3.3 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 6.4 | GO:0098552 | side of membrane(GO:0098552) |
0.3 | 1.1 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.3 | 0.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 0.5 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.3 | 0.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 1.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 0.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 1.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 6.3 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.3 | 0.5 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 6.5 | GO:0030118 | clathrin coat(GO:0030118) |
0.3 | 1.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.3 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 9.6 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 1.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 64.1 | GO:0005768 | endosome(GO:0005768) |
0.3 | 5.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.3 | 1.0 | GO:0044306 | axon terminus(GO:0043679) neuron projection terminus(GO:0044306) |
0.2 | 2.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 22.7 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 0.2 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 3.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 1.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.5 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 4.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 24.0 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 3.0 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.2 | 1.9 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 22.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 9.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.2 | 11.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.7 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.2 | 2.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 4.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 2.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.4 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 1.7 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 1.1 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.2 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 8.1 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 1.9 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 14.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 1.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.8 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 9.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 6.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.6 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 0.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 6.6 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.2 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 1.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.0 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 2.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 3.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 7.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 262.3 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 3.7 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.2 | GO:0030496 | midbody(GO:0030496) |
0.2 | 5.0 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.2 | 0.4 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 0.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 25.7 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.2 | 0.9 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 115.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.2 | GO:0044215 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.2 | 1.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 57.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 0.9 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.2 | 133.2 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.2 | 10.3 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.2 | 501.7 | GO:0005634 | nucleus(GO:0005634) |
0.2 | 1.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 0.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 445.0 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.2 | 0.6 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 2.1 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 0.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 3.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0005792 | obsolete microsome(GO:0005792) |
0.1 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.9 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.9 | GO:0030427 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.1 | 1.6 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 1.7 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.1 | 1.0 | GO:1990777 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.4 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 3.7 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 2.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.3 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.8 | GO:0005819 | spindle(GO:0005819) |
0.1 | 6.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 5.8 | GO:0031410 | cytoplasmic vesicle(GO:0031410) intracellular vesicle(GO:0097708) |
0.0 | 0.1 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.8 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 50.9 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 19.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
3.1 | 9.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.8 | 8.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
2.7 | 8.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.6 | 26.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.5 | 10.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.4 | 7.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
2.3 | 7.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.2 | 10.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
2.1 | 6.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.1 | 6.3 | GO:0033691 | sialic acid binding(GO:0033691) |
2.1 | 6.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.9 | 5.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.8 | 5.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.8 | 21.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.6 | 4.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.6 | 27.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.6 | 6.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.6 | 4.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.5 | 4.6 | GO:0035197 | siRNA binding(GO:0035197) |
1.5 | 1.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
1.5 | 9.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.5 | 25.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.5 | 9.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.5 | 11.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.5 | 4.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.5 | 17.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
1.4 | 7.2 | GO:0004904 | interferon receptor activity(GO:0004904) |
1.4 | 4.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.4 | 5.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.4 | 4.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.4 | 16.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.4 | 4.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
1.4 | 4.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.4 | 10.9 | GO:0050700 | CARD domain binding(GO:0050700) |
1.3 | 4.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.3 | 1.3 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
1.2 | 49.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.2 | 2.5 | GO:0001846 | opsonin binding(GO:0001846) |
1.2 | 4.9 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
1.2 | 8.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.2 | 4.9 | GO:0015925 | galactosidase activity(GO:0015925) |
1.2 | 25.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.2 | 4.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.2 | 1.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.2 | 7.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.2 | 9.5 | GO:0005522 | profilin binding(GO:0005522) |
1.2 | 9.3 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
1.1 | 4.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.1 | 3.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.1 | 2.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.1 | 7.9 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
1.1 | 3.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 6.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.1 | 1.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
1.1 | 2.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.1 | 7.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.1 | 3.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.1 | 5.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.1 | 3.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.1 | 5.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.1 | 4.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
1.0 | 2.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.0 | 9.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
1.0 | 6.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.0 | 2.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.0 | 3.0 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
1.0 | 5.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.0 | 5.0 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
1.0 | 4.0 | GO:0031014 | troponin T binding(GO:0031014) |
1.0 | 6.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.0 | 7.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.0 | 46.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.0 | 4.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.9 | 3.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.9 | 3.8 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.9 | 5.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.9 | 4.6 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.9 | 2.8 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.9 | 8.3 | GO:0019864 | IgG binding(GO:0019864) |
0.9 | 2.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.9 | 16.2 | GO:0043621 | protein self-association(GO:0043621) |
0.9 | 3.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.9 | 3.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.9 | 0.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.9 | 3.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.9 | 3.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.9 | 2.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.9 | 4.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.9 | 11.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.9 | 0.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.8 | 0.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.8 | 5.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.8 | 2.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.8 | 2.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.8 | 5.8 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.8 | 2.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.8 | 2.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.8 | 2.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.8 | 2.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.8 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.8 | 4.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.8 | 0.8 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.8 | 4.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.8 | 2.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.8 | 7.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.8 | 2.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 3.9 | GO:0030955 | potassium ion binding(GO:0030955) |
0.8 | 6.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.8 | 3.9 | GO:0048156 | tau protein binding(GO:0048156) |
0.8 | 5.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.8 | 2.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.8 | 3.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.8 | 3.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.8 | 5.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.7 | 2.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.7 | 6.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.7 | 2.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.7 | 5.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.7 | 5.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.7 | 1.5 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.7 | 18.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.7 | 1.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.7 | 2.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.7 | 10.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.7 | 2.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.7 | 8.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.7 | 6.3 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.7 | 1.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.7 | 1.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.7 | 2.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.7 | 0.7 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.7 | 2.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 12.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.7 | 4.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.7 | 2.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 3.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.6 | 1.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.6 | 2.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.6 | 4.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.6 | 1.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.6 | 3.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 1.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 1.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 3.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.6 | 1.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.6 | 0.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.6 | 3.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 3.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 1.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.6 | 1.2 | GO:0019209 | kinase activator activity(GO:0019209) |
0.6 | 1.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.6 | 4.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 2.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.6 | 6.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.6 | 6.7 | GO:0010181 | FMN binding(GO:0010181) |
0.6 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.6 | 10.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.6 | 1.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.6 | 2.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 1.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.6 | 4.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.6 | 3.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.6 | 1.2 | GO:0004527 | exonuclease activity(GO:0004527) |
0.6 | 1.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 2.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.6 | 5.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.6 | 0.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.6 | 7.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.6 | 2.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.6 | 1.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.6 | 1.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.6 | 4.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.6 | 8.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.6 | 2.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.6 | 5.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.6 | 1.1 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 17.0 | GO:0003823 | antigen binding(GO:0003823) |
0.6 | 3.4 | GO:0070513 | death domain binding(GO:0070513) |
0.6 | 6.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.6 | 2.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.6 | 1.7 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.6 | 2.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.6 | 0.6 | GO:0019863 | IgE binding(GO:0019863) |
0.6 | 3.3 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.6 | 1.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.6 | 6.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.6 | 1.7 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.6 | 0.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.6 | 1.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.6 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 3.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.5 | 4.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 13.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 1.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 1.1 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.5 | 1.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.5 | 2.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.5 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.5 | 4.2 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.5 | 2.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.5 | 1.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.5 | 1.6 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 28.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 1.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.5 | 1.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.5 | 1.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.5 | 2.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.5 | 5.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 1.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 1.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.5 | 13.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.5 | 2.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 1.5 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 4.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.5 | 1.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.5 | 2.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 12.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.5 | 2.4 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.5 | 16.9 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.5 | 1.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 5.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 2.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 5.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.5 | 1.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 0.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.5 | 1.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 1.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.5 | 1.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.5 | 1.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.5 | 5.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.5 | 1.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 5.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 1.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 5.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 3.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 1.8 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.4 | 0.9 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.4 | 0.9 | GO:0099528 | dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.4 | 7.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.4 | 6.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.4 | 12.1 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 2.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.4 | 3.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 1.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.4 | 0.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.4 | 5.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 4.6 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 2.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.4 | 3.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 2.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 1.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.4 | 3.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 46.7 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.4 | 15.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 2.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.4 | 3.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.4 | 2.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 1.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 4.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 2.0 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 2.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 1.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 1.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 2.4 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.4 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 2.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 0.4 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.4 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 2.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 5.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 2.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.4 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 2.3 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.4 | 30.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.4 | 2.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 1.1 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 1.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 1.1 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 1.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.4 | 3.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 4.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 1.5 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.4 | 1.5 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.4 | 1.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 1.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 1.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 9.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 1.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 17.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.4 | 3.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.4 | 0.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 0.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 1.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 3.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.3 | 0.3 | GO:0015440 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.3 | 2.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.7 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.3 | 3.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.3 | 1.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.3 | 1.7 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 6.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.3 | 1.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 3.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.3 | 1.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 4.7 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 2.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 1.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.3 | 3.0 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent protein deacetylase activity(GO:0034979) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.3 | 1.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 1.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 1.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 0.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 2.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 1.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 5.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.3 | 6.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 13.5 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 3.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.3 | 5.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 5.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 2.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 10.5 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.3 | 0.6 | GO:0043176 | amine binding(GO:0043176) |
0.3 | 1.3 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.3 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 11.1 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.3 | 3.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.3 | 0.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 5.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.3 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 1.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 2.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 3.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.3 | 1.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.3 | 1.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.3 | 0.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 2.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 3.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 0.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.3 | 1.5 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.3 | 7.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 2.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 7.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 0.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.3 | 1.5 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 1.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 3.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 0.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.3 | 1.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 3.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.3 | 1.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 4.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 1.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.3 | 1.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 0.9 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 4.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 1.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 0.3 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.3 | 0.6 | GO:0042806 | fucose binding(GO:0042806) |
0.3 | 1.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 4.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 9.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 4.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 0.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 4.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.3 | 1.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 0.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.3 | 2.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 6.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.3 | 0.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 1.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 1.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 1.1 | GO:0016887 | ATPase activity(GO:0016887) |
0.3 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 6.8 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.3 | 8.6 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.3 | 2.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 1.1 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.3 | 5.0 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.3 | 2.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.3 | 5.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 2.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.3 | 0.3 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.3 | 0.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 0.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 5.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 2.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 2.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.3 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 0.3 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 6.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.3 | 5.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 1.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 0.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 3.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.3 | 2.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 4.0 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.3 | 1.8 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.3 | 11.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.3 | 1.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 2.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 7.5 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.2 | 45.2 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.2 | 5.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 1.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 2.2 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.2 | 21.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 1.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 4.6 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.2 | 3.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 125.6 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 5.0 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.2 | 0.2 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.2 | 0.7 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.2 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 12.0 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 0.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.7 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 0.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 2.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.2 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 1.8 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 45.9 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 0.4 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.2 | 1.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 1.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.2 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 1.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 1.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 2.4 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.2 | 0.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 2.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 0.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 0.6 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 0.6 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.2 | 1.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 2.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.2 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.2 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.4 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.2 | 2.3 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.2 | 0.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 0.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 1.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.4 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.2 | 1.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 1.0 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.2 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.8 | GO:0019955 | cytokine binding(GO:0019955) |
0.2 | 5.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 2.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 3.9 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 1.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 3.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 2.3 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.2 | 1.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 1.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.2 | 8.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.6 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.7 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 0.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 0.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 3.6 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 0.2 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.2 | 0.2 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 2.7 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 1.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 1.0 | GO:0008144 | drug binding(GO:0008144) |
0.2 | 0.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 14.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 1.5 | GO:0019905 | syntaxin binding(GO:0019905) |
0.2 | 5.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 2.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.5 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 3.4 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.2 | 47.0 | GO:0019001 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.2 | 0.7 | GO:0005048 | signal sequence binding(GO:0005048) |
0.2 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 9.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 4.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 7.0 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.2 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.6 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.2 | 1.3 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.2 | 0.6 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.2 | 0.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.4 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.3 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 3.3 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.2 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 15.2 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 4.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 2.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 13.1 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 1.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 23.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 4.9 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 228.8 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 1.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.7 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 1.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 2.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 3.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 1.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 2.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.9 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 12.8 | GO:0016874 | ligase activity(GO:0016874) |
0.1 | 0.7 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 1.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 1.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 2.1 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.1 | 2.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 3.0 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 2.6 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 2.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 5.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 2.7 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 11.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 82.8 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.1 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 1.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 3.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 5.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 9.9 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 11.3 | GO:0004672 | protein kinase activity(GO:0004672) |
0.1 | 0.2 | GO:0016744 | transketolase activity(GO:0004802) transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 2.4 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 2.3 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 6.1 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.1 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 2.2 | GO:0015079 | potassium ion transmembrane transporter activity(GO:0015079) |
0.0 | 0.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 2.3 | GO:0004871 | signal transducer activity(GO:0004871) |
0.0 | 0.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.2 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.0 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 3.1 | GO:0005524 | ATP binding(GO:0005524) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.3 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 26.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
2.1 | 138.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.9 | 43.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.8 | 1.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.5 | 22.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.3 | 9.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.3 | 24.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.3 | 3.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.2 | 39.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.2 | 47.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.2 | 26.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.1 | 3.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.0 | 8.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.0 | 17.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.0 | 19.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.0 | 11.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.9 | 21.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.9 | 18.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.8 | 5.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.8 | 0.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.8 | 2.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.8 | 3.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.8 | 8.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.7 | 8.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.7 | 9.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.7 | 30.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 7.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.7 | 6.3 | PID EPO PATHWAY | EPO signaling pathway |
0.7 | 12.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.7 | 8.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 3.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 2.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.6 | 1.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.6 | 3.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 5.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.6 | 8.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 4.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.6 | 8.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.6 | 1.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.6 | 3.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.6 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.6 | 5.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 1.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.5 | 16.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 7.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.5 | 7.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.5 | 3.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 8.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.5 | 5.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.5 | 2.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.5 | 6.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 13.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 5.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 2.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.4 | 5.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 4.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 4.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 8.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 7.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.4 | 5.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 0.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.4 | 1.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 13.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 4.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 8.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 6.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 3.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 8.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 5.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 1.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 1.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 4.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 1.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 2.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 2.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 12.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 2.4 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 2.7 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 5.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 2.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 1.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 5.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 1.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 12.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 4.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 12.3 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 2.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 8.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 4.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 2.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 1.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 13.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 1.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 5.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 4.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 9.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 1.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 3.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 3.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 2.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.1 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 3.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 4.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 2.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 7.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 2.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 3.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 3.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 2.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 4.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 5.7 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 2.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 2.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 4.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 22.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 2.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.1 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 4.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
3.7 | 14.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
3.1 | 37.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.4 | 28.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
2.3 | 31.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.2 | 56.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.8 | 25.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.4 | 35.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.4 | 2.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.3 | 4.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.3 | 9.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.3 | 29.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.2 | 4.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.2 | 2.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.1 | 35.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
1.1 | 15.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.1 | 8.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.0 | 12.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.0 | 4.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
1.0 | 16.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.0 | 15.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.9 | 14.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.9 | 2.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.9 | 4.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.8 | 10.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.8 | 9.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.8 | 4.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.8 | 42.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.8 | 31.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.8 | 22.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 5.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.8 | 12.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.8 | 10.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 3.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.7 | 10.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.7 | 19.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.7 | 2.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.7 | 6.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.7 | 8.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.7 | 25.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.7 | 1.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.7 | 8.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.7 | 11.4 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.6 | 14.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 8.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.6 | 20.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.6 | 3.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 3.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.6 | 20.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 29.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.6 | 4.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 10.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.6 | 11.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.6 | 6.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 23.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 17.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 2.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 2.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.5 | 1.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.5 | 3.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 3.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.5 | 2.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.5 | 3.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.5 | 14.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 9.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 6.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 9.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.5 | 11.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.5 | 7.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.5 | 2.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.5 | 9.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.5 | 4.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.5 | 1.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 33.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.4 | 2.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 1.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 2.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.4 | 5.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.4 | 18.7 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.4 | 8.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 3.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 0.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.4 | 6.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 6.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 1.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 3.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 1.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 3.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 5.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 2.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 2.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 12.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 10.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 10.9 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.3 | 5.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 15.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 3.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 2.2 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.3 | 2.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 0.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.3 | 4.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 28.7 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.3 | 4.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 0.9 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.3 | 0.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.3 | 8.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 7.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 4.9 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.3 | 7.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 4.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 4.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 0.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 0.8 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.3 | 8.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.3 | 1.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 3.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 9.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 3.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 2.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 16.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 2.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 1.4 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.2 | 3.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 3.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 6.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 15.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 25.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 3.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 2.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 2.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 3.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 20.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 3.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 3.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 3.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 2.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 2.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 0.6 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.2 | 13.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 1.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 0.7 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 12.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 3.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 7.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 6.0 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 3.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 2.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 0.5 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 7.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 4.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 4.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 2.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 3.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 1.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 7.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 2.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 1.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.8 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 7.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 5.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 2.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 2.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 29.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.6 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 2.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 4.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 23.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 0.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 1.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 2.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.9 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 1.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.5 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 1.1 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.5 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
0.0 | 0.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |